Dendrimer-based magnetic iron oxide nanoparticles: their synthesis and biomedical applications

Drug Discovery Today

Volumn 21, Issue 12, 2016, Pages 1873-1885

  Sun, Wenjie ^a   Mignani, Serge ^b   Shen, Mingwu ^a   Shi, Xiangyang ^a  

^a DONGHUA UNIVERSITY   (China)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRIMER; MAGNETIC IRON OXIDE NANOPARTICLE; NANOCOMPOSITE; NANOPARTICLE; NANOSHELL; UNCLASSIFIED DRUG; FERRIC ION; FERRIC OXIDE; MAGNETITE; METAL NANOPARTICLE;

DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; GENE DELIVERY SYSTEM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN IMMOBILIZATION; REVIEW; ANIMAL; CHEMISTRY; HUMAN; MAGNETISM; SYNTHESIS;

ANIMALS; DENDRIMERS; FERRIC COMPOUNDS; FERROSOFERRIC OXIDE; HUMANS; MAGNETIC PHENOMENA; METAL NANOPARTICLES;

EID: 84979581734     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2016.06.028     Document Type: Review

References (110)

1. 1 Amstad, E., et al. Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging. Small 5 (2009), 1334–1342.
2. 2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles. Biomaterials 32 (2011), 4584–4593.
3. 1-weighted MR imaging of gliomas. Nanoscale 7 (2015), 14538–14546.
4. 4 Yang, J., et al. Conjugation of iron oxide nanoparticles with RGD-modified dendrimers for targeted tumor MR imaging. ACS Appl. Mater. Interfaces 7 (2015), 5420–5428.
5. 5 Xing, R.J., et al. Hollow iron oxide nanoparticles as multidrug resistant drug delivery and imaging vehicles. Nano Res. 6 (2013), 1–9.
6. 6 Chen, J., et al. Reducible polyamidoamine-magnetic iron oxide self-assembled nanoparticles for doxorubicin delivery. Biomaterials 35 (2014), 1240–1248.
7. 7 Jiang, S., et al. Lipidoid-coated iron oxide nanoparticles for efficient DNA and siRNA delivery. Nano Lett. 13 (2013), 1059–1064.
8. 8 Xiao, S.L., et al. PAMAM dendrimer/pDNA functionalized-magnetic iron oxide nanoparticles for gene delivery. J. Biomed. Nanotechnol. 11 (2015), 1370–1384.
9. 9 Jeyapragasam, T., Saraswathi, R., Electrochemical biosensing of carbofuran based on acetylcholinesterase immobilized onto iron oxide–chitosan nanocomposite. Sens. Actuator B Chem. 191 (2014), 681–687.
10. 10 Hwang, S.W., et al. Synthesis and characterization of iron oxide nanoparticles for phenyl hydrazine sensor applications. Sens. Lett. 12 (2014), 97–101.
11. 11 Yu, C.H., et al. Immobilization of BSA on silica-coated magnetic iron oxide nanoparticle. J. Phys. Chem. C 113 (2008), 537–543.
12. 12 Demir, M., et al. Reversible immobilization of BSA on Cu-chelated PAMAM dendrimer modified iron oxide nanoparticles. Appl. Surf. Sci. 314 (2014), 697–703.
13. 13 Thomas, L.A., et al. Carboxylic acid-stabilised iron oxide nanoparticles for use in magnetic hyperthermia. J. Mater. Chem. 19 (2009), 6529–6535.
14. 14 Kossatz, S., et al. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery. Breast Cancer Res., 17, 2015, 66.
15. 15 Xu, H.Y., et al. Antibody conjugated magnetic iron oxide nanoparticles for cancer cell separation in fresh whole blood. Biomaterials 32 (2011), 9758–9765.
16. 4 superparamagnetic nanoparticles for cancer cell separation. Mol. Med. Rep. 9 (2014), 1080–1084.
17. 17 Strable, E., et al. Synthesis and characterization of soluble iron oxide-dendrimer composites. Chem. Mater. 13 (2001), 2201–2209.
18. 18 Walter, A., et al. Functionalization strategies and dendronization of iron oxide nanoparticles. Nanotechnol. Rev. 4 (2015), 581–593.
19. 19 Ayala, V., et al. Effect of surface charge on the colloidal stability and in vitro uptake of carboxymethyl dextran-coated iron oxide nanoparticles. J. Nanopart. Res. 15 (2013), 1–14.
20. 20 Chen, Y.J., et al. Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent. Drug Dev. Ind. Pharm. 36 (2010), 1235–1244.
21. 21 Reddy, A.M., et al. Functional characterization of mesenchymal stem cells labeled with a novel PVP-coated superparamagnetic iron oxide. Contrast Media Mol. Imaging 4 (2009), 118–126.
22. 22 Javid, A., et al. Chitosan-coated superparamagnetic iron oxide nanoparticles for doxorubicin delivery: synthesis and anticancer effect against human ovarian cancer cells. Chem. Biol. Drug Des. 82 (2013), 296–306.
23. 23 Tomalia, D.A., et al. A new class of polymers: starburst-dendritic macromolecules. Polym. J. 17 (1985), 117–132.
24. 24 Tomalia, D.A., Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic organic chemistry. Aldrichim. Acta 37 (2004), 39–57.
25. 25 Cheng, Y.Y., et al. Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives. Chem. Soc. Rev. 40 (2011), 2673–2703.
26. 26 Karatasos, K., et al. Statics and dynamics of model dendrimers as studied by molecular dynamics simulations. J. Chem. Phys. 115 (2001), 5310–5318.
27. 27 Sadekar, S., Ghandehari, H., Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery. Adv. Drug Delivery Rev. 64 (2012), 571–588.
28. 28 Zhang, W.L., et al. Gadolinium-conjugated FA-PEG-PAMAM-COOH nanoparticles as potential tumor-targeted circulation-prolonged macromolecular MRI contrast agents. J. Appl. Polym. Sci. 118 (2010), 1805–1814.
29. 29 Shi, X.Y., et al. Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging. Small 3 (2007), 1245–1252.
30. 30 Liu, Z.M., et al. A hydrogen peroxide biosensor based on nano-Au/PAMAM dendrimer/cystamine modified gold electrode. Sens. Actuator B Chem. 106 (2005), 394–400.
31. 31 Wen, S.H., et al. Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes. Adv. Healthcare Mater. 2 (2013), 1267–1276.
32. 32 Shen, M., Shi, X., Dendrimer-based organic/inorganic hybrid nanoparticles in biomedical applications. Nanoscale 2 (2010), 1596–1610.
33. 33 Qiao, Z., Shi, X.Y., Dendrimer-based molecular imaging contrast agents. Prog. Polym. Sci. 44 (2015), 1–27.
34. 34 Shi, X.Y., et al. Characterization of crystalline dendrimer-stabilized gold nanoparticles. Nanotechnology 17 (2006), 1072–1078.
35. 35 Balogh, L., et al. Dendrimer-silver complexes and nanocomposites as antimicrobial agents. Nano Lett. 1 (2001), 18–21.
36. 36 Shi, X.Y., et al. Synthesis, characterization, and manipulation of dendrimer-stabilized iron sulfide nanoparticles. Nanotechnology 17 (2006), 4554–4560.
37. 37 Chandra, S., et al. Dendrimer-functionalized magnetic nanoparticles: a new electrode material for electrochemical energy storage devices. J. Power Sources 280 (2015), 217–226.
38. 4-nanoparticle arrays coated with PEGylated-dendrimers. Mater. Chem. Phys. 132 (2012), 292–299.
39. 39 Yu, J.X., et al. Effect of surface functionality of magnetic silica nanoparticles on the cellular uptake by glioma cells in vitro. J. Mater. Chem. 19 (2009), 1265–1270.
40. 40 Li, Z.M., et al. Arginine-glycine-aspartic acid-conjugated dendrimer-modified quantum dots for targeting and imaging melanoma. J. Nanosci. Nanotechnol. 10 (2010), 4859–4867.
41. 41 Shi, X.Y., et al. Synthesis, characterization, and intracellular uptake of carboxyl-terminated poly(amidoamine) dendrimer-stabilized iron oxide nanoparticles. Phys. Chem. Chem. Phys. 9 (2007), 5712–5720.
42. 42 Frankamp, B.L., et al. Direct control of the magnetic interaction between iron oxide nanoparticles through dendrimer-mediated self-assembly. J. Am. Chem. Soc. 127 (2005), 9731–9735.
43. 43 Xu, X.H., et al. Cooperative hierarchical self-assembly of peptide dendrimers and linear polypeptides into nanoarchitectures mimicking viral capsids. Angew. Chem. 124 (2012), 3184–3187.
44. 44 Zhang, Y., et al. A new strategy for assembling multifunctional nanocomposites with iron oxide and amino-terminated PAMAM dendrimers. J. Mater. Sci. Mater. Med. 20 (2009), 2433–2440.
45. 45 Wang, S.H., et al. Dendrimer-functionalized iron oxide nanoparticles for specific targeting and imaging of cancer cells. Adv. Funct. Mater. 17 (2007), 3043–3050.
46. 46 Shi, X.Y., et al. Dendrimer-functionalized shell-crosslinked iron oxide nanoparticles for in-vivo magnetic resonance imaging of tumors. Adv. Mater. 20 (2008), 1671–1678.
47. 4@Au nanocomposite particles for dual mode magnetic resonance and computed tomography imaging applications. J. Mater. Chem. 22 (2012), 15110–15120.
48. 4/Au nanocomposite particles for targeted dual mode CT/MR imaging of tumors. Small 11 (2015), 4584–4593.
49. 49 Gao, H., et al. Dendrimer-encapsulated copper as a novel oligonucleotides label for sensitive electrochemical stripping detection of DNA hybridization. Biosens. Bioelectron. 48 (2013), 210–215.
50. 50 Esumi, K., et al. Preparation of hydrophobically modified poly(amidoamine) dendrimer-encapsulated gold nanoparticles in organic solvents. J. Colloid Interface Sci. 229 (2000), 303–306.
51. 51 Wilson, O.M., et al. Synthesis, characterization, and structure-selective extraction of 1–3-nm diameter AuAg dendrimer-encapsulated bimetallic nanoparticles. J. Am. Chem. Soc. 127 (2005), 1015–1024.
52. 52 Scott, R.W.J., et al. Synthesis, characterization, and stability of dendrimer-encapsulated palladium nanoparticles. Chem. Mater. 15 (2003), 3873–3878.
53. 53 Knecht, M.R., et al. Synthesis and characterization of Pt dendrimer-encapsulated nanoparticles: effect of the template on nanoparticle formation. Chem. Mater. 20 (2008), 5218–5228.
54. 54 Aranishi, K., et al. Dendrimer-encapsulated bimetallic Pt–Ni nanoparticles as highly efficient catalysts for hydrogen generation from chemical hydrogen storage materials. Chemcatchem 5 (2013), 2248–2252.
55. 55 Wu, X.C., et al. Synthesis, photoluminescence, and adsorption of CdS/dendrimer nanocomposites. J. Phys. Chem. B 109 (2005), 230–239.
56. 56 Fahmi, A., et al. Water-soluble CdSe nanoparticles stabilised by dense-shell glycodendrimers. New J. Chem. 33 (2009), 703–706.
57. 57 Domracheva, N.E., et al. Iron-containing poly(propylene imine) dendromesogens with photoactive properties. Macromol. Chem. Phys. 211 (2010), 791–800.
58. 3 nanoparticles encapsulated into liquid-crystalline poly(propylene imine) dendrimers. Chemphyschem 12 (2011), 3009–3019.
59. 59 Dykes, G.M., Dendrimers: a review of their appeal and applications. J. Chem. Technol. Biotechnol. 76 (2001), 903–918.
60. 60 Tomalia, D.A., et al. Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew. Chem., Int. Ed. Engl. 29 (1990), 138–175.
61. 61 Tomalia, D.A., et al. Dendritic macromolecules: synthesis of starburst dendrimers. Macromolecules 19 (1986), 2466–2468.
62. 62 Liu, H.B., et al. Fabrication and functionalization of dendritic poly(amidoamine)-immobilized magnetic polymer composite microspheres. J. Phys. Chem. B 112 (2008), 3315–3321.
63. 63 Pan, B.F., et al. Growth of multi-amine terminated poly(amidoamine) dendrimers on the surface of carbon nanotubes. Nanotechnology 17 (2006), 2483–2489.
64. 64 Abu-Reziq, R., et al. Metal supported on dendronized magnetic nanoparticles: highly selective hydroformylation catalysts. J. Am. Chem. Soc. 128 (2006), 5279–5282.
65. 65 Liu, W.M., et al. Dendrimer modified magnetic iron oxide nanoparticle/DNA/PEI ternary magnetoplexes: a novel strategy for magnetofection. J. Mater. Chem. 21 (2011), 13306–13315.
66. 66 Pan, B.F., et al. Dendrimer modified magnetite nanoparticles for protein immobilization. J. Colloid Interface Sci. 284 (2005), 1–6.
67. 67 Pan, B.F., et al. Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system. Cancer Res. 67 (2007), 8156–8163.
68. 68 Tajabadi, M., et al. An efficient method of SPION synthesis coated with third generation PAMAM dendrimer. Colloid Surf. A Physicochem. Eng. Asp. 431 (2013), 18–26.
69. 69 Khodadust, R., et al. PAMAM dendrimer-coated iron oxide nanoparticles: synthesis and characterization of different generations. J. Nanopart. Res., 15, 2013, 1488.
70. 70 Wang, Y.Y., et al. Dendrimer modified magnetic nanoparticles for immobilized BSA: a novel chiral magnetic nano-selector for direct separation of racemates. J. Mat. Chem. B 1 (2013), 5028–5035.
71. 71 Gibson, H.W., et al. Molecular self-assembly of dendrimers, non-covalent polymers and polypseudorotaxanes. Polym. Adv. Technol. 11 (2000), 791–797.
72. 72 Abbasi, E., et al. Dendrimers: synthesis, applications, and properties. Nanoscale Res. Lett. 9 (2014), 1–10.
73. 73 Caminade, A.M., et al. Dendrimers and hyperbranched polymers. Chem. Soc. Rev. 44 (2015), 3870–3873.
74. 74 Lai, T.P., et al. Patent blue derivatized dendronized iron oxide nanoparticles for multimodal imaging. Eur. J. Inorg. Chem. 27 (2015), 4565–4571.
75. 75 Rehm, T.H., et al. Proof of concept: magnetic fixation of dendron-functionalized iron oxide nanoparticles containing palladium nanoparticles for continuous-flow suzuki coupling reactions. ACS Appl. Mater. Interfaces 7 (2015), 27254–27261.
76. 76 Walter, A., et al. Modulation of relaxivity, suspension stability, and biodistribution of dendronized iron oxide nanoparticles as a function of the organic shell design. Part. Part. Syst. Charact. 32 (2015), 552–560.
77. 77 Basly, B., et al. Properties and suspension stability of dendronized iron oxide nanoparticles for MRI applications. Contrast Media Mol. Imaging 6 (2011), 132–138.
78. 78 Basly, B., et al. Effect of the nanoparticle synthesis method on dendronized iron oxides as MRI contrast agents. Dalton Trans. 42 (2013), 2146–2157.
79. 79 Na, H.B., et al. Inorganic nanoparticles for MRI contrast agents. Adv. Mater. 21 (2009), 2133–2148.
80. 4 dendron-nanocrystals dispersible in both organic and aqueous solutions. Adv. Mater. 17 (2005), 1429–1432.
81. 81 Rouhollah, K., et al. Doxorubicin loading, release, and stability of polyamidoamine dendrimer-coated magnetic nanoparticles. J. Pharm. Sci. 102 (2013), 1825–1835.
82. 4-PAMAM-GNPs nanocomposites and HRP-MWCNTs-Ab bioconjugates for signal amplification. Sens. Actuator B Chem. 156 (2011), 71–78.
83. 83 Wu, J.W., et al. Immobilization of HSA on polyamidoamine-dendronized magnetic microspheres for application in direct chiral separation of racemates. J. Mater. Chem. B 2 (2014), 775–782.
84. 84 Chandra, S., et al. Combining unique properties of dendrimers and magnetic nanoparticles towards cancer theranostics. J. Biomed. Nanotechnol. 10 (2014), 32–49.
85. 85 Laurent, S., et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 108 (2008), 2064–2110.
86. 86 Langereis, S., et al. Dendrimers and magnetic resonance imaging. New J. Chem. 31 (2007), 1152–1160.
87. 87 Yan, G.P., et al. Dendrimers as carriers for contrast agents in magnetic resonance imaging. Chin. Sci. Bull. 55 (2010), 3085–3093.
88. 88 Bulte, J.W.M., Kraitchman, D.L., Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 17 (2004), 484–499.
89. 89 Sun, W.J., et al. Dendrimer-based nanodevices as contrast agents for MR imaging applications. Adv. Nanotheranostics 6 (2016), 249–270.
90. 90 Bulte, J.W.M., et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 19 (2001), 1141–1147.
91. 91 Lee, I.H., et al. In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord. Exp. Neurol. 187 (2004), 509–516.
92. 92 Tunici, P., et al. Brain engraftment and therapeutic potential of stem/progenitor cells derived from mouse skin. J. Gene. Med. 8 (2006), 506–513.
93. 93 He, X.H., et al. Functionalization of magnetic nanoparticles with dendritic-linear-brush-like triblock copolymers and their drug release properties. Langmuir 28 (2012), 11938–11947.
94. 94 Wu, X.M., et al. Water-soluble dendritic-linear triblock copolymer-modified magnetic nanoparticles: preparation, characterization and drug release properties. J. Mater. Chem. 21 (2011), 13611–13620.
95. 4-doxorubicin triads with the potential for improved therapeutic efficacy: generation-dependent increased drug loading and retention at neutral pH and increased release at acidic pH. Langmuir 30 (2014), 1004–1011.
96. 96 Chang, Y.L., et al. Novel water-soluble and pH-responsive anticancer drug nanocarriers: doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs). J. Colloid Interface Sci. 363 (2011), 403–409.
97. 97 Fang, J., et al. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Deliv. Rev. 63 (2011), 136–151.
98. 98 Chang, Y.L., et al. Synthesis and characterization of DOX-conjugated dendrimer-modified magnetic iron oxide conjugates for magnetic resonance imaging, targeting, and drug delivery. J. Mater. Chem. 22 (2012), 9594–9601.
99. 99 Chang, Y.L., et al. Dendrimer functionalized water soluble magnetic iron oxide conjugates as dual imaging probe for tumor targeting and drug delivery. Polym. Chem. 4 (2013), 789–794.
100. 100 Taratula, O., et al. Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes. Curr. Drug Deliv. 8 (2011), 59–69.
101. 101 Gary, D.J., et al. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. J. Control. Release 121 (2007), 64–73.
102. 102 Santos, J.L., et al. Functionalization of poly (amidoamine) dendrimers with hydrophobic chains for improved gene delivery in mesenchymal stem cells. J. Control. Release 144 (2010), 55–64.
103. 103 Santos, J.L., et al. Receptor-mediated gene delivery using pamam dendrimers conjugated with peptides recognized by mesenchymal stem cells. Mol. Pharmaceutics 7 (2010), 763–774.
104. 104 Xiao, T., et al. Poly(amidoamine) dendrimers modified with 1,2-epoxyhexane or 1,2-epoxydodecane for enhanced gene delivery applications. J. Nanosci. Nanotechnol. 15 (2015), 10134–10140.
105. 105 Gersting, S.W., et al. Gene delivery to respiratory epithelial cells by magnetofection. J. Gene. Med. 6 (2004), 913–922.
106. 106 Schillinger, U., et al. Advances in magnetofection-magnetically guided nucleic acid delivery. J. Magn. Magn. Mater. 293 (2005), 501–508.
107. 107 Plank, C., Magnetofection: enhancing and targeting gene delivery with lipid–DNA vectors by magnetic force. J. Liposome Res. 13 (2003), 105–106.
108. 108 Cao, M., et al. Food related applications of magnetic iron oxide nanoparticles: enzyme immobilization, protein purification, and food analysis. Trends Food Sci. Technol. 27 (2012), 47–56.
109. 3 nanoparticles. Spectroc. Acta A Molec. Biomolec. Spectr. 125 (2014), 359–362.
110. 110 Uzun, K., et al. Covalent immobilization of invertase on PAMAM-dendrimer modified superparamagnetic iron oxide nanoparticles. J. Nanopart. Res. 12 (2010), 3057–3067.